Lower risk Drug recall · FDA · Published December 12, 2025

Merck Emend Oral Suspension Recall: Metal Particulates Risk

Merck recalls 125mg single-dose Emend oral suspension due to potential metal particulates. Affected units have specific NDC and lot numbers. Consumers should check their product details.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0241-2026Drug Merck ›

Lower-risk recall

Presence of particulate matter: potential presence of metal particulates in the product.

Take action

Contact the company

Recalling firmMerck Sharp & Dohme LLC4633 Merck Rd W · Wilson, NC 27893-9613

✎ GovInfoNow plain-language explainer

Merck is recalling a specific 125mg single-dose Emend oral suspension product because it may contain metal particles. This could cause injury if the particles enter the body during use. Read more at govinfonow.com/recall/31618-merck-emend-oral-suspension-recall-metal-particulates-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/31618-merck-emend-oral-suspension-recall-metal-particulates-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0241-2026

Cite this page

“Merck Emend Oral Suspension Recall: Metal Particulates Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31618-merck-emend-oral-suspension-recall-metal-particulates-risk. Based on FDA recall #D-0241-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0241-2026%22&limit=1).

The FDA announced on Dec. 12, 2025, that Merck Sharp & Dohme LLC voluntarily recalled Merck Emend (aprepitant) for oral suspension due to the potential presence of metal particulates. Owners should stop using the product immediately.

How to tell if you have it

Brand: Merck
Product: Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit
NDC: 0006-3066-03
Lot #: Z014503
Expiration: 11/15/2027

The hazard

The recall addresses the potential presence of metal particulates in the product, according to the FDA. The agency classified this as a Class II recall.

Context

GovInfoNow's records show other recent recalls involving metal particulate risks include the Asteria Health ESTRADIOL 22mg Pellet Recall on Jan. 26, 2026, and the FarmaKeio Testosterone Pellets Recall on Oct. 14, 2025. Another similar recall occurred with the Asteria Health ESTRADIOL Pellets Recall on Jan. 26, 2026.

How to tell if you have this one

Check for the NDC code 0006-3066-03 and lot number Z014503 on the product label. The product is a 125mg single-dose oral suspension for chemotherapy treatment.

Brand
Merck
Category
Drug

FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

Classification
Class II
Status
Ongoing
Distribution
Nationwide in the USA

Recall number	Product, codes & lots	Quantity	NDC
D-0241-2026	Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03; Lot #: Z014503, Exp 11/15/2027	3 - single dose kits	0006-0461-02, 0006-0461-01, 0006-0461-06, 0006-0461-12, 0006-0462-01, 0006-0462-06, 0006-3862-03, 0006-3862-13, 0006-0464-01, 0006-0464-10, 0006-0464-05, 0006-3066-01, 0006-3066-03
D-0242-2026	Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.; Lot#: Z012339, Z010344, Z009908, Z009909, Exp Date 12-31-2026	845 kits	0085-1328-01, 0085-4324-02, 0085-4331-01, 0085-2224-01, 0085-2224-02

Based on the official FDA remedy

What to do — step by step

Check Product Details
Look for the NDC code 0006-3066-03 and lot number Z014503 on the product label.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 19 days after the firm started it.

Dec 12, 2025Firm started the recall
Dec 23, 2025FDA classified it Class II
Dec 31, 2025Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/31618-merck-emend-oral-suspension-recall-metal-particulates-risk">Merck Emend Oral Suspension Recall: Metal Particulates Risk (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0241-2026 (December 12, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0241-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.